GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Common Stock

Rhythm Biosciences (ASX:RHY) Common Stock : A$31.82 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Common Stock?

Rhythm Biosciences's quarterly common stock increased from Dec. 2022 (A$31.03 Mil) to Jun. 2023 (A$31.55 Mil) and increased from Jun. 2023 (A$31.55 Mil) to Dec. 2023 (A$31.82 Mil).

Rhythm Biosciences's annual common stock increased from Jun. 2021 (A$15.98 Mil) to Jun. 2022 (A$27.84 Mil) and increased from Jun. 2022 (A$27.84 Mil) to Jun. 2023 (A$31.55 Mil).


Rhythm Biosciences Common Stock Historical Data

The historical data trend for Rhythm Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Common Stock Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial 10.04 10.04 15.98 27.84 31.55

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.47 27.84 31.03 31.55 31.82

Rhythm Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Rhythm Biosciences (ASX:RHY) Business Description

Traded in Other Exchanges
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines